https://www.selleckchem.com/pr....oducts/vafidemstat.h
2 vs. 7.0 per 100 person-year; adjusted hazard ratio 1.53; 95% confidence interval 0.84 to 2.79; p=0.2). Comparedwith TAVR in nonrheumatic AS, TAVR for rheumatic AS was associated with similar mortality (15.2 vs. 17.7 deaths per 100 person-years (adjusted hazard ratio 0.87; 95% confidence interval 0.68 to 1.09; p=0.2) after median follow-up of 17months (interquartile range 11 to 24months). None of the rheumatic TAVR patients,11 SAVR patients, and 242 nonrheumatic TAVR patients underwent repeat aortic valve replacement (124 redo-
お気に入り
コメント
シェア
